![NEHC - New Era Helium Inc - Stock Price Chart]() |
Market Cap | 6.16M | EPS (ttm) | -1.30 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -914.89% |
P/S | 12.08 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -873.58% |
Dividend | - | Sales Q/Q | - |
Insider Own | 57.07% | Inst Own | 2.14% |
Insider Trans | 0.00% | Inst Trans | 23.63% |
Short Float | 37.17% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 5.42M | 52W Range | 0.42 - 12.29 |
|
|
|
New Era Helium, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX. |
|
 |
![BHVN - Biohaven Ltd - Stock Price Chart]() |
Market Cap | 1.41B | EPS (ttm) | -9.37 |
P/E | - | EPS this Y | 16.89% |
Forward P/E | - | EPS next Y | 17.54% |
PEG | - | EPS past 5Y | -49.78% |
P/S | - | EPS next 5Y | 17.95% |
P/B | 5.43 | EPS Q/Q | 1.15% |
Dividend | - | Sales Q/Q | - |
Insider Own | 12.68% | Inst Own | 88.80% |
Insider Trans | 0.25% | Inst Trans | -1.70% |
Short Float | 12.20% | Earnings | May 12/a |
Analyst Recom | 1.25 | Target Price | 54.21 |
Avg Volume | 2.19M | 52W Range | 13.87 - 55.70 |
|
|
|
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
CHILDS JOHN W | Director | Mar 04 '25 | Buy | 30.47 | 32,700 | 996,238 | 2,320,571 | Mar 05 07:01 AM | Car Bruce | Chief Scientific Officer | Jan 05 '25 | Option Exercise | 0.00 | 4,750 | 0 | 7,133 | Jan 07 08:51 PM | Gentile Kimberly | SVP, Clinical Operations | Jan 05 '25 | Option Exercise | 0.00 | 3,750 | 0 | 99,719 | Jan 07 08:50 PM | Clark George C. | VP, Chief Accounting Officer | Jan 05 '25 | Option Exercise | 0.00 | 2,500 | 0 | 66,168 | Jan 07 08:50 PM | Buten Matthew | Chief Financial Officer | Jan 05 '25 | Option Exercise | 0.00 | 4,250 | 0 | 196,013 | Jan 07 08:49 PM |
|
|
 |
![ZJYL - Jin Medical International Ltd - Stock Price Chart]() |
Market Cap | 90.06M | EPS (ttm) | 0.02 |
P/E | 24.48 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 0.61% |
P/S | 3.83 | EPS next 5Y | - |
P/B | 3.13 | EPS Q/Q | 69.01% |
Dividend | - | Sales Q/Q | 35.29% |
Insider Own | 75.84% | Inst Own | 0.64% |
Insider Trans | 0.00% | Inst Trans | -49.38% |
Short Float | 1.19% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 212.23K | 52W Range | 0.56 - 4.38 |
|
|
|
Jin Medical International Ltd. is a holding company, which engages in the design, development, manufacture, and sale of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The company was founded on January 14, 2020 and is headquartered in Changzhou, China. |
|
|  |
![HLP - Hongli Group Inc - Stock Price Chart]() |
Market Cap | 52.58M | EPS (ttm) | -0.15 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 3.73 | EPS next 5Y | - |
P/B | 0.98 | EPS Q/Q | -94.64% |
Dividend | - | Sales Q/Q | 0.85% |
Insider Own | 35.39% | Inst Own | 0.00% |
Insider Trans | 0.00% | Inst Trans | -77.42% |
Short Float | 0.08% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 188.37K | 52W Range | 0.71 - 2.12 |
|
|
|
Hongli Group, Inc. is a holding company, which engages in conducting its businesses through its subsidiaries. Its business operation focuses on the design, production, deep processing, and sales of custom-made profile for machinery and equipment. The company was founded on February 9, 2021 and is headquartered in Weifang, China. |
|
 |
![CAI - Caris Life Sciences Inc - Stock Price Chart]() |
Market Cap | 7.37B | EPS (ttm) | -10.43 |
P/E | - | EPS this Y | 19.50% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 16.30 | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | 49.90% |
Insider Own | 48.50% | Inst Own | 2.20% |
Insider Trans | 0.03% | Inst Trans | 49.92% |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 2.53M | 52W Range | 25.56 - 30.70 |
|
|
|
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Spetzler David Baxley | President | Jun 20 '25 | Option Exercise | 2.44 | 75,000 | 183,000 | 558,668 | Jun 23 06:41 PM | Denton John Russel | See Remarks | Jun 20 '25 | Buy | 21.00 | 7,500 | 157,500 | 123,591 | Jun 23 06:34 PM | Brille Brian J | See Remarks | Jun 20 '25 | Buy | 21.00 | 30,000 | 630,000 | 162,428 | Jun 23 06:30 PM |
|
|
|  |
![PINE - Alpine Income Property Trust Inc - Stock Price Chart]() |
Market Cap | 207.30M | EPS (ttm) | 0.09 |
P/E | 157.76 | EPS this Y | -180.03% |
Forward P/E | 416.93 | EPS next Y | 131.11% |
PEG | - | EPS past 5Y | -21.32% |
P/S | 3.84 | EPS next 5Y | -6.52% |
P/B | 0.87 | EPS Q/Q | -321.99% |
Dividend | 7.87% | Sales Q/Q | 13.96% |
Insider Own | 8.59% | Inst Own | 64.65% |
Insider Trans | -0.20% | Inst Trans | -2.90% |
Short Float | 1.42% | Earnings | Jul 24/a |
Analyst Recom | 1.50 | Target Price | 18.54 |
Avg Volume | 78.13K | 52W Range | 14.51 - 19.42 |
|
|
|
Alpine Income Property Trust, Inc. is a real estate company, which owns and operates a portfolio of single-tenant commercial properties. The company was founded on August 19, 2019 and is headquartered in Winter Park, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Richardson Andrew C | Director | Feb 24 '25 | Sale | 16.64 | 2,000 | 33,278 | 17,143 | Feb 26 06:00 PM | Richardson Andrew C | Director | Feb 25 '25 | Sale | 16.71 | 400 | 6,683 | 16,743 | Feb 26 06:00 PM | Richardson Andrew C | Director | Feb 24 '25 | Proposed Sale | 16.54 | 4,000 | 66,160 | | Feb 24 01:12 PM | Elias Wein Rachel | Director | Nov 22 '24 | Sale | 18.00 | 2,000 | 36,000 | 9,492 | Nov 22 05:30 PM | Richardson Andrew C | Director | Nov 21 '24 | Sale | 17.73 | 500 | 8,867 | 19,143 | Nov 22 05:25 PM |
|
|
 |
![AVNS - Avanos Medical Inc - Stock Price Chart]() |
Market Cap | 547.07M | EPS (ttm) | -8.36 |
P/E | - | EPS this Y | -37.04% |
Forward P/E | 10.75 | EPS next Y | 29.41% |
PEG | - | EPS past 5Y | -54.63% |
P/S | 0.79 | EPS next 5Y | - |
P/B | 0.65 | EPS Q/Q | 823.08% |
Dividend | - | Sales Q/Q | 0.84% |
Insider Own | 3.21% | Inst Own | 94.45% |
Insider Trans | -0.47% | Inst Trans | 0.98% |
Short Float | 3.73% | Earnings | May 06/b |
Analyst Recom | 3.00 | Target Price | 14.00 |
Avg Volume | 461.58K | 52W Range | 11.75 - 25.36 |
|
|
|
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Holbrook Kerr | SVP, Chief Commercial Officer | Mar 06 '25 | Sale | 15.25 | 7,000 | 106,778 | 82,047 | Mar 10 11:50 AM | Holbrook Kerr | Officer | Mar 06 '25 | Proposed Sale | 15.25 | 7,000 | 106,780 | | Mar 06 05:05 PM | James Mojirade | SVP, General Counsel | Mar 04 '25 | Option Exercise | 0.00 | 8,039 | 0 | 78,352 | Mar 06 02:25 PM | Woody Joseph Fralin | Former Chief Executive Officer | Mar 04 '25 | Option Exercise | 0.00 | 32,158 | 0 | 453,203 | Mar 06 02:25 PM | Holbrook Kerr | SVP, Chief Commercial Officer | Mar 04 '25 | Option Exercise | 0.00 | 5,145 | 0 | 92,393 | Mar 06 02:24 PM |
|
|
|  |
![FLO - Flowers Foods, Inc - Stock Price Chart]() |
Market Cap | 3.31B | EPS (ttm) | 1.07 |
P/E | 14.60 | EPS this Y | -14.06% |
Forward P/E | 13.84 | EPS next Y | 3.12% |
PEG | - | EPS past 5Y | 8.55% |
P/S | 0.65 | EPS next 5Y | -3.02% |
P/B | 2.34 | EPS Q/Q | -27.47% |
Dividend | 6.28% | Sales Q/Q | -1.43% |
Insider Own | 7.50% | Inst Own | 78.79% |
Insider Trans | 0.08% | Inst Trans | 7.53% |
Short Float | 8.77% | Earnings | May 16/b |
Analyst Recom | 2.88 | Target Price | 18.43 |
Avg Volume | 2.59M | 52W Range | 15.74 - 23.87 |
|
|
|
Flowers Foods, Inc. engages in the production and marketing of packaged bakery foods. It offers breads, buns, rolls, snack items, bagels, English muffins, and tortillas and are sold under a variety of brand names, including Nature's Own, Dave's Killer Bread, Wonder, Canyon Bakehouse, Tastykake, and Mrs. Freshley's. The company was founded by William Howard Flowers, Sr. and Joseph Hampton Flowers, Jr. in 1919 and is headquartered in Thomasville, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DEESE GEORGE E | Director | May 27 '25 | Buy | 16.84 | 6,000 | 101,039 | 2,004,990 | May 28 12:24 PM | McFadden William Jameson | Director | May 22 '25 | Option Exercise | 0.00 | 6,570 | 0 | 529,476 | May 27 06:34 PM | McFadden William Jameson | Director | May 27 '25 | Buy | 16.92 | 3,000 | 50,760 | 532,476 | May 27 06:34 PM | Chubb Thomas Caldecot III | Director | May 22 '25 | Option Exercise | 0.00 | 6,570 | 0 | 42,861 | May 27 03:42 PM | Chubb Thomas Caldecot III | Director | May 27 '25 | Buy | 16.88 | 3,000 | 50,640 | 45,861 | May 27 03:42 PM |
|
|
 |
![JAMF - Jamf Holding Corp - Stock Price Chart]() |
Market Cap | 1.17B | EPS (ttm) | -0.37 |
P/E | - | EPS this Y | 35.62% |
Forward P/E | 9.17 | EPS next Y | 17.47% |
PEG | - | EPS past 5Y | -13.80% |
P/S | 1.83 | EPS next 5Y | 17.39% |
P/B | 1.57 | EPS Q/Q | 102.36% |
Dividend | - | Sales Q/Q | 10.19% |
Insider Own | 49.50% | Inst Own | 47.82% |
Insider Trans | -0.73% | Inst Trans | 1.18% |
Short Float | 5.06% | Earnings | May 06/a |
Analyst Recom | 1.54 | Target Price | 18.30 |
Avg Volume | 914.91K | 52W Range | 8.87 - 19.05 |
|
|
|
Jamf Holding Corp. engages in the provision of a complete management and security solution for an Apple-first environment that is designed to be enterprise secure, consumer simple, and protective of personal privacy. It operates through the following geographical segments: The Americas, Europe, the Middle East, India, and Africa, and Asia Pacific. The company was founded in 2002 and is headquartered in Minneapolis, MN. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bucaria Michelle | CPO | Jun 17 '25 | Sale | 9.37 | 15,393 | 144,255 | 257,473 | Jun 18 06:27 PM | Bucaria Michelle | CPO | Jun 16 '25 | Sale | 9.57 | 5,712 | 54,651 | 272,866 | Jun 18 06:27 PM | MICHELLE BUCARIA | Officer | Jun 17 '25 | Proposed Sale | 9.55 | 15,393 | 147,003 | | Jun 17 04:32 PM | MICHELLE BUCARIA | Officer | Jun 16 '25 | Proposed Sale | 9.47 | 5,712 | 54,093 | | Jun 16 04:33 PM | STROSAHL JOHN | CEO | Jun 05 '25 | Sale | 10.75 | 16,125 | 173,313 | 1,524,101 | Jun 06 06:06 PM |
|
|
 |
![KMTS - Kestra Medical Technologies Ltd - Stock Price Chart]() |
Market Cap | 757.39M | EPS (ttm) | -1.90 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 14.39 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -2.24% |
Dividend | - | Sales Q/Q | 82.31% |
Insider Own | 67.05% | Inst Own | 26.31% |
Insider Trans | 0.00% | Inst Trans | -4.72% |
Short Float | 6.71% | Earnings | Jul 15/a |
Analyst Recom | 1.33 | Target Price | 27.50 |
Avg Volume | 243.32K | 52W Range | 14.15 - 26.15 |
|
|
|
Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company was founded by Brian Webster and Phillip D. Foshee in 2014 and is headquartered in Kirkland, WA. |
|
|